Please assess the completion status of the following clinical trial:

Trial Title: Efficacy Study of Pudendal Neuromodulation for the Treatment of Neurogenic Overactive Bladder

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: CROSSOVER
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Incomplete upper motor neuron lesion~* Detrusor overactivity~* Two leaks or two notices of leaks per day~* Mean functional bladder capacity (volume voided per episode) of ≥100 ml~Exclusion Criteria:~* Complete spinal lesion or complete bilateral lesion of sacral / pudendal nerves.~* Degenerative disease of the central nervous system

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- ON / OFF (Type: OTHER): Stimulation ON for 4 weeks, followed by stimulation OFF for 4 weeks.
- OFF / ON (Type: OTHER): Stimulation OFF for 4 weeks, followed by stimulation ON for 4 weeks.

Based on this trial design, predict the completion outcome and termination type (if applicable).